IMPRESA SGPS SA (IPR.LS) Fundamental Analysis & Valuation

ELI:IPR • PTIPR0AM0000

0.183 EUR
-0.01 (-3.17%)
Last: Mar 5, 2026, 07:00 PM

This IPR.LS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

IPR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 65 industry peers in the Media industry. IPR has a bad profitability rating. Also its financial health evaluation is rather negative. IPR has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. IPR.LS Profitability Analysis

1.1 Basic Checks

  • IPR had negative earnings in the past year.
  • IPR had a positive operating cash flow in the past year.
  • In multiple years IPR reported negative net income over the last 5 years.
  • In the past 5 years IPR always reported a positive cash flow from operatings.
IPR.LS Yearly Net Income VS EBIT VS OCF VS FCFIPR.LS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M -60M

1.2 Ratios

  • IPR has a Return On Assets of -20.73%. This is amonst the worse of the industry: IPR underperforms 81.54% of its industry peers.
  • IPR has a Return On Equity of -79.68%. This is amonst the worse of the industry: IPR underperforms 83.08% of its industry peers.
Industry RankSector Rank
ROA -20.73%
ROE -79.68%
ROIC N/A
ROA(3y)-6.58%
ROA(5y)-2.74%
ROE(3y)-24.75%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
IPR.LS Yearly ROA, ROE, ROICIPR.LS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • IPR has a worse Gross Margin (33.46%) than 67.69% of its industry peers.
  • In the last couple of years the Gross Margin of IPR has declined.
  • IPR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 33.46%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
IPR.LS Yearly Profit, Operating, Gross MarginsIPR.LS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. IPR.LS Health Analysis

2.1 Basic Checks

  • IPR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • IPR has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, IPR has about the same amount of shares outstanding.
  • IPR has a worse debt/assets ratio than last year.
IPR.LS Yearly Shares OutstandingIPR.LS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
IPR.LS Yearly Total Debt VS Total AssetsIPR.LS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

  • IPR has an Altman-Z score of -0.35. This is a bad value and indicates that IPR is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -0.35, IPR is doing worse than 83.08% of the companies in the same industry.
  • IPR has a debt to FCF ratio of 15.65. This is a negative value and a sign of low solvency as IPR would need 15.65 years to pay back of all of its debts.
  • IPR's Debt to FCF ratio of 15.65 is in line compared to the rest of the industry. IPR outperforms 44.62% of its industry peers.
  • IPR has a Debt/Equity ratio of 1.15. This is a high value indicating a heavy dependency on external financing.
  • IPR's Debt to Equity ratio of 1.15 is in line compared to the rest of the industry. IPR outperforms 41.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 15.65
Altman-Z -0.35
ROIC/WACCN/A
WACC5.49%
IPR.LS Yearly LT Debt VS Equity VS FCFIPR.LS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • A Current Ratio of 0.44 indicates that IPR may have some problems paying its short term obligations.
  • IPR's Current ratio of 0.44 is on the low side compared to the rest of the industry. IPR is outperformed by 83.08% of its industry peers.
  • IPR has a Quick Ratio of 0.44. This is a bad value and indicates that IPR is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.44, IPR is doing worse than 81.54% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.44
Quick Ratio 0.44
IPR.LS Yearly Current Assets VS Current LiabilitesIPR.LS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

0

3. IPR.LS Growth Analysis

3.1 Past

  • IPR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -2807.97%.
  • The Revenue has decreased by -3.29% in the past year.
  • Measured over the past years, IPR shows a decrease in Revenue. The Revenue has been decreasing by -0.34% on average per year.
EPS 1Y (TTM)-2807.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.89%
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-1.12%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IPR.LS Yearly Revenue VS EstimatesIPR.LS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M
IPR.LS Yearly EPS VS EstimatesIPR.LS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 0.01 0.02 0.03 0.04 0.05

2

4. IPR.LS Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for IPR. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
IPR.LS Price Earnings VS Forward Price EarningsIPR.LS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

  • 96.92% of the companies in the same industry are more expensive than IPR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.16
EV/EBITDA N/A
IPR.LS Per share dataIPR.LS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. IPR.LS Dividend Analysis

5.1 Amount

  • IPR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

IPR.LS Fundamentals: All Metrics, Ratios and Statistics

IMPRESA SGPS SA

ELI:IPR (3/5/2026, 7:00:00 PM)

0.183

-0.01 (-3.17%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A
Earnings (Next)03-11
Inst Owners0.21%
Inst Owner ChangeN/A
Ins Owners1.51%
Ins Owner ChangeN/A
Market Cap30.74M
Revenue(TTM)176.02M
Net Income(TTM)-67.42M
Analysts84
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.17
P/FCF 3.16
P/OCF 2.58
P/B 0.36
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.4
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.06
FCFY31.67%
OCF(TTM)0.07
OCFY38.8%
SpS1.05
BVpS0.5
TBVpS-0.74
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.73%
ROE -79.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 33.46%
FCFM 5.53%
ROA(3y)-6.58%
ROA(5y)-2.74%
ROE(3y)-24.75%
ROE(5y)-11.67%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.81%
GM growth 5Y-10.84%
F-Score4
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 1.15
Debt/FCF 15.65
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales 1.25%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.44
Quick Ratio 0.44
Altman-Z -0.35
F-Score4
WACC5.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)1.24%
Cap/Sales(5y)1.39%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2807.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-26.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.29%
Revenue growth 3Y-2.2%
Revenue growth 5Y-0.34%
Sales Q2Q%-1.12%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-550.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y48.6%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y35.5%
OCF growth 3Y-57.59%
OCF growth 5Y-39.33%

IMPRESA SGPS SA / IPR.LS FAQ

What is the fundamental rating for IPR stock?

ChartMill assigns a fundamental rating of 1 / 10 to IPR.LS.


What is the valuation status for IPR stock?

ChartMill assigns a valuation rating of 2 / 10 to IMPRESA SGPS SA (IPR.LS). This can be considered as Overvalued.


How profitable is IMPRESA SGPS SA (IPR.LS) stock?

IMPRESA SGPS SA (IPR.LS) has a profitability rating of 1 / 10.